Mirum Pharmaceuticals, Inc.
MIRM
Kedudukan dalam Saham
#3271
Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to... Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixibat to address intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Founded in 2018, Mirum Pharmaceuticals, Inc. operates from its headquarters in Foster City, California.
Harga Saham
$82.73
Modal Pasaran
$5.37B
Perubahan (1 hari)
0.60%
Perubahan (1 tahun)
13.28%
Negara
US
Perdagangan Mirum Pharmaceuticals, Inc. (MIRM)
Kategori
Healthcare
Sejarah pecahan saham untuk Mirum Pharmaceuticals, Inc. (MIRM)
Saham Mirum Pharmaceuticals, Inc. (simbol: MIRM) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Oct 20, 2026.
Satu saham MIRM yang dibeli sebelum Oct 20, 2026 kini bersamaan dengan 0 saham MIRM.
Pecahan saham terkini berlaku pada Oct 20, 2026.
Satu saham MIRM yang dibeli sebelum Oct 20, 2026 kini bersamaan dengan 0 saham MIRM.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| Tidak cukup data untuk tarikh yang disediakan. | |||
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
